88 related articles for article (PubMed ID: 34439224)
1. RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792024
[TBL] [Abstract][Full Text] [Related]
2. Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.
Kiffin R; Grauers Wiktorin H; Nilsson MS; Aurelius J; Aydin E; Lenox B; Nilsson JA; Ståhlberg A; Thorén FB; Hellstrand K; Martner A
Front Oncol; 2018; 8():218. PubMed ID: 29967760
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-tumor activities in human leukemia-derived cells of polyenylpyrroles with a methyl group at the conjugated polyene terminus.
Higashi T; Yoshida C; Hachiro Y; Nakata C; Takechi A; Yagi T; Miyashita K; Kitada N; Obata R; Hirano T; Hara T; Maki SA
Bioorg Med Chem Lett; 2023 Oct; 95():129471. PubMed ID: 37717362
[TBL] [Abstract][Full Text] [Related]
4. Aberrant stem cell and developmental programs in pediatric leukemia.
Ling RE; Cross JW; Roy A
Front Cell Dev Biol; 2024; 12():1372899. PubMed ID: 38601080
[TBL] [Abstract][Full Text] [Related]
5. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
6. Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy.
Sami SA; Darwish NHE; Barile ANM; Mousa SA
Curr Treat Options Oncol; 2020 Jan; 21(1):3. PubMed ID: 31933183
[TBL] [Abstract][Full Text] [Related]
7. Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management.
Sudha T; Godugu K; Darwish NHE; Nazeer T; Mousa SA
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439224
[TBL] [Abstract][Full Text] [Related]
8. Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia.
Darwish NHE; Glinsky GV; Sudha T; Mousa SA
Front Oncol; 2021; 11():793810. PubMed ID: 35155195
[TBL] [Abstract][Full Text] [Related]
9. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204997
[TBL] [Abstract][Full Text] [Related]
10. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2019 Dec; 30(12):3087-3097. PubMed ID: 31714064
[TBL] [Abstract][Full Text] [Related]
11. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α
Sudha T; Godugu K; Glinsky GV; Mousa SA
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453545
[TBL] [Abstract][Full Text] [Related]
12. Discovery of dual targeting PEGylated BG-P
Ozen Karakus O; Godugu K; Mousa SA
Bioorg Med Chem; 2021 Aug; 43():116278. PubMed ID: 34157571
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of NF-κB Signaling Alters Acute Myelogenous Leukemia Cell Transcriptomics.
Reikvam H
Cells; 2020 Jul; 9(7):. PubMed ID: 32664684
[TBL] [Abstract][Full Text] [Related]
14. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Davis PJ; Mousa SA; Lin HY
Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]